The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 29, 2023

Filed:

Mar. 21, 2022
Applicant:

Bristol-myers Squibb Company, Princeton, NJ (US);

Inventors:

Alaric J. Dyckman, Lawrenceville, NJ (US);

Dharmpal S. Dodd, San Diego, CA (US);

Christopher P. Mussari, Princeton, NJ (US);

Trevor C. Sherwood, West Windsor, NJ (US);

John L. Gilmore, Yardley, PA (US);

Tasir Shamsul Haque, Yardley, PA (US);

Brian K. Whiteley, Lebanon, NJ (US);

David R. Tortolani, Skillman, NJ (US);

Shoshana L. Posy, Highland Park, NJ (US);

John E. Macor, Washington Crossing, PA (US);

Louis J. Lombardo, Belle Mead, NJ (US);

Ramesh Kumar Sistla, Bangalore, IN;

Anupama Kandhi Ramachandra Reddy, Bangalore, IN;

Subramanya Hegde, Bangalore, IN;

Laxman Pasunoori, Warangal, IN;

Sreekantha Ratna Kumar, Bangalore, IN;

Assignee:

Bristol-Myers Squibb Company, Princeton, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/14 (2006.01); C07D 405/14 (2006.01); C07D 413/14 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 495/04 (2006.01); C07D 498/04 (2006.01); C07D 513/04 (2006.01);
U.S. Cl.
CPC ...
C07D 498/04 (2013.01); C07D 401/14 (2013.01); C07D 405/14 (2013.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 495/04 (2013.01); C07D 513/04 (2013.01);
Abstract

Disclosed are compounds of Formula (I) or salts thereof, wherein Ring Het, R, R, R, R, R, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.


Find Patent Forward Citations

Loading…